| Literature DB >> 30965223 |
Diana Rey1, Paola Miranda Sulis2, Thaís Alves Fernandes2, Renata Gonçalves2, Marisa Jádna Silva Frederico2, Geison M Costa3, Marcela Aragon4, Luís Fernando Ospina4, Fátima Regina Mena Barreto Silva5.
Abstract
Astragalin is a flavonol glycoside with several biological activities, including antidiabetic properties. The objective of this study was to investigate the effects of astragalin on glycaemia and insulin secretion, in vivo, and on calcium influx and insulin secretion in isolated rat pancreatic islets, ex vivo. Astragalin (1 and 10 mg / kg) was administered by oral gavage to fasted Wistar rats and serum glucose and plasma insulin were measured. Isolated pancreatic islets were used to measure basal insulin secretion and calcium influx. Astragalin (10 mg/ kg) decreased glycaemia and increased insulin secretion significantly at 15-180 min, respectively, in the glucose tolerance test. In isolated pancreatic cells, astragalin (100 μM) stimulated calcium influx through a mechanism involving ATP-dependent potassium channels, L-type voltage-dependent calcium channels, the sarcoendoplasmic reticulum calcium transport ATPase (SERCA), PKC and PKA. These findings highlight the dietary coadjuvant, astragalin, as a potential insulin secretagogue that may contribute to glucose homeostasis.Entities:
Keywords: Calcium signaling; Glycaemia; Insulin secretion; Medicinal plants
Year: 2019 PMID: 30965223 DOI: 10.1016/j.ceca.2019.03.009
Source DB: PubMed Journal: Cell Calcium ISSN: 0143-4160 Impact factor: 6.817